210 related articles for article (PubMed ID: 30232694)
21. Multitarget stool DNA testing for colorectal-cancer screening.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
[TBL] [Abstract][Full Text] [Related]
22. Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: the importance of cancer prevention in addition to cancer detection.
Pickhardt PJ
Abdom Radiol (NY); 2016 Aug; 41(8):1441-4. PubMed ID: 27259335
[TBL] [Abstract][Full Text] [Related]
23. Fecal occult blood testing.
Sanford KW; McPherson RA
Clin Lab Med; 2009 Sep; 29(3):523-41. PubMed ID: 19840685
[TBL] [Abstract][Full Text] [Related]
24. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.
Iannone A; Losurdo G; Pricci M; Girardi B; Massaro A; Principi M; Barone M; Ierardi E; Di Leo A
J Gastrointest Cancer; 2016 Jun; 47(2):143-51. PubMed ID: 26922358
[TBL] [Abstract][Full Text] [Related]
25. FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.
Borges LV; Mattar R; Silva JMKD; Silva ALWD; Carrilho FJ; Hashimoto CL
Arq Gastroenterol; 2018; 55(2):128-132. PubMed ID: 30043860
[TBL] [Abstract][Full Text] [Related]
26. Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design.
Juul JS; Bro F; Hornung N; Andersen BS; Laurberg S; Olesen F; Vedsted P
BMC Cancer; 2016 Jul; 16():445. PubMed ID: 27400657
[TBL] [Abstract][Full Text] [Related]
27. False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.
Ibañez-Sanz G; Garcia M; Milà N; Rodríguez-Moranta F; Binefa G; Gómez-Matas J; Benito L; Padrol I; Barenys M; Moreno V
Eur J Cancer Prev; 2017 Sep; 26(5):365-367. PubMed ID: 27433880
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing.
Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L
Dig Dis Sci; 2018 Jun; 63(6):1449-1453. PubMed ID: 29516325
[TBL] [Abstract][Full Text] [Related]
29. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
[TBL] [Abstract][Full Text] [Related]
31. Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer.
Faivre J; Dancourt V; Denis B; Dorval E; Piette C; Perrin P; Bidan JM; Jard C; Jung S; Levillain R; Viguier J; Bretagne JF
Eur J Cancer; 2012 Nov; 48(16):2969-76. PubMed ID: 22572481
[TBL] [Abstract][Full Text] [Related]
32. Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.
Ibáñez-Sanz G; Garcia M; Rodríguez-Moranta F; Binefa G; Gómez-Matas J; Domènech X; Vidal C; Soriano A; Moreno V;
Dig Liver Dis; 2016 Oct; 48(10):1249-54. PubMed ID: 27378703
[TBL] [Abstract][Full Text] [Related]
33. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications.
Beswick L; Ting A; Macrae F; Dowling D; Hair C
Intern Med J; 2014 Dec; 44(12a):1264-5. PubMed ID: 25442767
[No Abstract] [Full Text] [Related]
34. The cost-effectiveness of immunochemical tests for colorectal cancer screening.
Lejeune C; Le Gleut K; Cottet V; Galimard C; Durand G; Dancourt V; Faivre J
Dig Liver Dis; 2014 Jan; 46(1):76-81. PubMed ID: 24012177
[TBL] [Abstract][Full Text] [Related]
35. Screening for colorectal cancer with immunochemical faecal occult blood tests.
Faivre J; Dancourt V; Lejeune C
Dig Liver Dis; 2012 Dec; 44(12):967-73. PubMed ID: 22898146
[TBL] [Abstract][Full Text] [Related]
36. False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.
Garcia M; Milà N; Binefa G; Borràs JM; Espinàs JA; Moreno V
J Med Screen; 2012 Jun; 19(2):77-82. PubMed ID: 22653571
[TBL] [Abstract][Full Text] [Related]
37. Screening: Early alert.
Willyard C
Nature; 2015 May; 521(7551):S4-5. PubMed ID: 25970456
[No Abstract] [Full Text] [Related]
38. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
[TBL] [Abstract][Full Text] [Related]
39. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
40. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]